Home
About
Posts
Comments
Email
The Leading Information Source for Chronic Disease Research and Management
Metabolic
Type I Diabetes
Type II Diabetes
Neuropathy
Retinopathy
Thyroid Disorder
Addisons Disease
Dialysis
Kidney Disorders
Obesity
Cardiovascular
Hypertension
Cardiac Arrythmias
Coronary Artery Disease
Heart failure
Angina
Central Nervous System
Parkinson's Disease
Schizophrenia
ADHD
Anxiety
Depression
Epilepsy
Obsessive Compulsive Disorder
Alzheimer
Dementia
Fibromyalgia
Lou Gehrig's
Respiratory
Asthma
Bronchiectasis
Cystic Fibrosis
Chronic Obstructive Airways Disease
Cancer
Bladder
Brain
Breast
Cervical
Colon
Leukemia
Liver
Lung
Ovarian
Prostate
Viral
HIV
Hepatitis
Herpes
Tuberculosis
Industry News
Clinical Trials
Employment News
FDA
Investments
M&A
Politics
Preclinical Trials
Gastrointestinal
Crohn's Disease
Pancreatic Disease
Blood Conditions
Bone and Blood Conditions
Lifestyle
Osteoporosis
Software
General Message
2010
3SBio
800-847-6060
A. Sidney Barritt
ADL5747
ADL5859
ADVENTRX Pharmaceuticals
AEterna Zentaris
AG1000
AG200-15
AIDS
ALS
AMG 479
ANA598
AQX-1125
ARN-509
ARRY-162
ASCO
ASCO 2010
ATX-101
AVEO Pharmaceuticals
AVI Biopharma
Aaron Kowalski
Aastrom Biosciences
Abbie Celniker
Abbott Labs
Abraxis BioScience
Abraxis Pharmaceutical
Academic Medical Center
Accentia Pharmaceuticals
Achaogen
Achillion Pharmaceuticals
Acrux
Actelion
Actemra
Actos
Acura Pharmaceuticals
Acurox
Adam
Adam Autona
Adimab
Adolor
Adrian Adams
AesRx
Affimed Therapeutics
Affymaxm
Afrezza
Africa
Agile Therapeutics
Agios Pharmaceuticals
AiCuris
Alain Froment
Albany Molecular Research
Albert Einstein College of Medicine
Alcoholism
Alectos
Alexander Denner
Alexion Pharmaceuticals
Alexis Borisy
Alimera Sciences
Allan Bradley
Allergan
AlloCure
Alnara Pharmaceuticals
Alnylam Pharmaceuticals
AlphaVax
Alzheimer's
Alzheimer's / Dementia
Ambrx
American Academy
Amgen
Amsterdam Molecular Therapeutics
Amylin pharmaceuticals
Amyris Biotechnologies
Anacor Pharmaceuticals
Anadys Pharmaceuticals
Anchor Therapeutics
Andrea Dunaif
Andrew Witty
Anika Therapeutics
Ann Arbor
Antares Pharma
Antibiotics
Antigenics
Antonio Zorzano
Anturol
Apath
Apexigen
Aplastic Anemia
April 2010
Aptuit
Aquinox
ArQule
Aradigm
Aragon Pharmaceuticals
Arcalyst
Archimedes
Arena Pharmaceuticals
Ariad Pharmaceuticals
Array BioPharma
Arthritis / Rheumatology
Aryx Therapeutics
Ascenta Therapeutics
Asia
Assistant
Astellas Pharma
AstraZeneca
Athens
Athersys
Aton Pharma
August 2010
Autoimmune Disease
Avandia
Avastin
Avexa
Avid Radiopharmaceuticals
Avila Therapeutics
Axanum
BARDA
BCX4208
BD
BIND Biosciences
BIO
BIO 2010
BMI
Barcelona
Basilea Pharmaceutica
Bayer Healthcare
Bayer Schering
Beate Ritz
Becton, Dickinson and Company
Belatacept
Benlysta
Beth Deaconess Medical Center
Beth Israel
Big Biotech
Big Pharma
Bill and Melinda Gates Foundation
BioBAT
BioMarin Pharmaceutical
BioMerieux
BioSante Pharmaceuticals
BioScale
Biocryst
Biogen Idec
Biologics
Biology / Biochemistry
Biomedicine
Biotech CEO
Biotech IPO
Biotech Stock
Biotech Venture Capital
Biotech deals
Biovail
Bipolar
Bisphosphonates
Boehringer Ingelheim
Bones / Orthopedics
Boston
Boston Red Sox
BrainCells
Brazil
Breast Cancer
Brian J. Zikmund-Fisher
Brigham and Women's Hospital
Brilinta
Bristol-Myers Squibb
Brown University
Bruce Spiegelman
Bruxelles
Business
Bydureon
Byetta
CGI Pharmaceuticals
CHD
CHS Pharma
CK-1
COPD
CPEX Pharmaceuticals
CRO
CSL
CXL-1020
Cadence Pharmaceuticals
California
Calistoga Pharmaceuticals
Calithera Biosciences
Cambridge
Campath
Cancer / Oncology
Cancer Drugs
Cancer Prevention
Cancer Research
Cara Therapeutics
Cardiome Pharma
Cardiovascular / Cardiology
Cardioxyl Pharmaceuticals
Caribbean
Carl Icahn
Carlos Bustamante
Carlos Museum
Carlos Rodriguez
Case Western Reserve University
Catabasis Pharmaceuticals
Catena
CeNeRx BioPharma
Celator Pharmaceuticals
Celebrex
Celgene
Cell Therapeutics
Celldex Therapeutics
Cellerant Therapeutics
Cellular Dynamics
Centocor Ortho Biotech
Ceplene
Cerenis Therapeutics
Cerezyme
Chapel Hill
Charles River
Charles Wambebe
ChemoFx
Chicago
Chicago Medical Center
Chorus
Chris Viehbacher
Christian de Virgilio
Christoph Westphal
Christopher Benson
Chulalongkorn University
Chulalongkorn University, Bangkok
Chutes and Ladders
Cialis
Cincinnati
Cipla
Ciprofloxacin
City
Clarus Ventures
Clayton Foundation Laboratories
Clayton Laboratories
Cleveland Biolabs
Clinical Medicine
Clinical Trial
Clinical Trial Results
Clinical Trials / Drug Trials
Clopidogrel
Clovis Oncology
Codexis
Columbia
Columbia University
Columbia University Medical Center
CombiMatrix
Commission of European Communities
Complete Genomics
Concert Pharmaceuticals
Conferences
Conflict of interest
Congress
ConjuChem
Connecticut
Constellation Pharma
Consulting
Contrave
Convulsions
Copenhagen
Coridon
Cornell University
Cornerstone Therapeutics
Corticosteroids
Covance
Cowen Healthcare Royalty Partners
Critical Path Initiative
Cuba
Cumberland Pharmaceuticals
CureVac
Curis
Cushing's Syndrome
Cypress Bioscience
Cytheris
Cytori Therapeutics
Cytos Biotechnology
D
D. Redelmeier
DNage
Daiichi Sankyo
Dainippon Sumitomo
Dana
David Barker
David Packard
Daxas
Deaconess Medical Center
Delcath
Dendreon
Dengue fever
Denmark
Denosumab
Dentistry
Depomed
Development deals
Diabetes
Diabetes Care
Diabetes Surgery Summit
Diamyd
Diana Kerwin
Dicerna Pharmaceuticals
Dickson Mounds
Disaster
Discovery Labs
Dominican Republic
Dong-Hoon Kim
Donna M. Zulman
Dov Lichtenberg
Dov Pharmaceutical
Dr. Patrick Soon-Shiong
Dr. Steven Nissen
Drotrecogin Alpha
Drug Discovery
Drug approvals
Dublin
Dulera
Durect
E. Lonn
E5555
EMEA
EMEA Approval
Economic development
Edith King
Edward Mascioli
Efalizumab
Effient
Eisai
Elan
Eli Lilly
Ella
Emergent BioSolutions
Emisphere
Emory University
Endo Pharmaceuticals
Endocrinology
Endocyte
Entereg
Entertainment
Environment
EpiCept
Epitomics
Eric Herlenius
Ernest N. Morial
Esme Fuller-Thomson
Esophageal Cancer
Euthymics Bioscience
Eva Schernhammer
Evan Snyder
Eve A. Kerr
Evotec
Excelimmune
Exelixis
ExonHit Therapeutics
Experimental Drugs
Eye Health / Blindness
FDA application process
FDA approval
FDA priority review
FDA regulation
FDA rejection
FTY720
Fatigue
Featured
February 2010
Femta
FerroKin Biosciences
Finland
Finnish Institute
Finnish Institute of Occupational Health
Florida
Flutiform
FoldRx Pharmaceuticals
Food and Drug Administration
Forecasting
Forest Laboratories
Foundation Medicine
Fragile X Research
France
Francis Collins
Francisco
Frank Abboud
Frank Anania
GAINESVILLE
GDC-0449
GLG Pharma
GPS
GSK-299423
GTC Biotherapeutics
GTx
GW Pharma
Gail Donnelly
Galapagos
Gardasil
Gemin X Pharmaceuticals
Gen-Probe
GenMab
Genentech
General Electric
Generic Biologics
Genetics
Genocea Biosciences
Genomics Institute
Genvec
Genzyme
George Armelagos
George Scangos
Georgia
Geron
Gestiva
Gilead Sciences
Gilenia
GlaxoSmithKline
Glenmark Pharmaceuticals
Global
GlobeImmune
Glumetza
Gomberg
Google Ventures
Gordon McInnes
Graduate School
Grazax
Greek Organisation Against Drugs
Grifols
Gustavo Saposnik
H1N1
HCV
HCV RNA
HCV treatment
HIV/AIDS
HRA Pharma
Hall F
Harold Hines Jr.
Harvard
Hasbro
Hawaii Biotech
Health Insurance / Medical Insurance
Healthcare Ventures
Helicos BioSciences
Helixis
Helsinki
HemaQuest Pharmaceuticals
Hematide
Hemispherx Biopharma
Henri Termeer
Hepatitis C
Hong Lu
Horizant
Horizon Therapeutics
Hospira
Human Genome Sciences
Human Interest
Huntington's Disease
Hypertension Treatment
IK-1001
INC Research
INO-8875
INX-189
IT / Internet / E-mail
Igenica
Ikaria
Illinois
Illumina
Iluvien
Ilya Pinchuk
Imatinib Mesylate
Immune Design
ImmunoCellular Therapeutics
ImmunoGen
ImmunoSolv
Incline Therapeutics
Incyte Corporation
Infections
Infectious Diseases
Infectious Diseases / Bacteria / Viruses
Infinity Pharmaceuticals
Inhibitex
Inotek Pharmaceuticals
Inspire Pharmaceuticals
Insulin
Intellikine
Intercell
Intermune
Ionsys
Iowa
Ipsen
Ireland
Ironwood Pharmaceuticals
Isis Pharmaceuticals
Island Hospital
Isoniazid
Isotechnika
Israel
Italy
Itero Biopharmaceuticals
J. Carver Biomedical Chair
J. Craig Venter
JDRF JDRF
JZP-6
James Mullen
James Wright
Jan van de Winkel
Janine Galone
Janssen
January 2010
Japan
Javelin Pharmaceuticals
Jazz Pharmaceuticals
Jean-Marie Bodo
Jeff Williamson
Jennifer G. Robinson
Joel Ray
John Fitzpatrick
John Lechleiter
John Nolan
John Wiley Sons
Johnson Johnson
Jolla
Jonas Salk
Jorge R. Oksenberg
Jorgen Olsen
Jose Carlos Gutierrez-Ramos
July 2010
June 2010
KNS-760704
KV Pharmaceutical
Karen L. Margolis
Karo Bio
Katarzyna Bryca
Keryx Biopharmaceuticals
Kevin Fiscella
Kidney Diseases
Kineta
King Pharmaceuticals
Kissei Pharmaceutical
Knome
Knopp Neurosciences
Kymab
Kythera Biopharmaceuticals
Labor
Lambda Canada
Lansing
Latin America
Law
Lei Qian
Lewis H. Kuller
Lewis Kuller
Licensing deals
Life Technologies
Lillian R. Meacham
Linaclotide
LipimetiX
Lisa Drakeman
Liver Disease / Hepatitis
Liver Fibrosis
Liver transplant
Lobbying
Logical Therapeutics
London
Los Angeles
Lou Gehrig's disease
Lovenox
Loxoprofen
Lucile Packard
Lung Disease
Lycera
MBX-2982
MDD PROVIDENCE
MDRNA
MGI Pharma
MK-4305
MRC Technology
MRI
MRSA
Magnetic Resonance Imaging
Mannkind
Mapatumumab
March 2010
Marco Prado
Mardi Gomberg-Maitland
Margaret Hamburg
Marian Limacher
Marianna Virtanen
Marie B. Gale
Marina
Mark Chapleau
Mark O. Huising
Mark Zimmerman
Market Access
Market Research
Marketing
Marshall Edwards
Martin Mackay
Mary Ellen Michele Heisler
Maryland
Massachusetts
Massachusetts Biotechnology Council
Mater Misericordiae University Hospital
Matthew R. Nelson
May 2010
Mayo Clinic
MedImmune
Medical College of Wisconsin, Milwaukee
Medical Device
Medical Devices / Diagnostics
Medicines for Malaria Venture
Medtronic
Melanoma
Memorial Hospital
Mepact
Merck
Merck KgAA
Merck Serono
Mergers and Acquisitions
Mersana Therapeutics
Mesoblast
Metabasis Therapeutics
Metabolex
Metabolic Control
Metabolic Disturbances
Metabolic Research Group
Metabolix
Metoclopramide
Mexico
Michael Welsh
Michigan
Michigan Agricultural Experiment Station
Michigan State University
MiddleBrook Pharmaceuticals
Mikael Dolsten
Millennium Pharmaceuticals
Millipore
Milwaukee
Minneapolis
Minnesota
Mirina Corporation
Molecular and Cellular Biology
Molly Rosen Chair
Montefiore Medical Center
Moshe Leshno
Movetis
Multiple Sclerosis
Myriad Genetics
Myriad Pharmaceuticals
NDM-1
NICE
NME approvals
NOV-002
NSF update
NVC-422
Nastech
National Cancer Institute
National Institute of Health
National Institutes of Health
National Science Foundation
Nautilus Neurosciences
Nektar Therapeutics
Nereus Pharmaceuticals
Neupogen
NeurogesX
Neurological Disorders
Neurology / Neuroscience
Neuroscience
New England
New Jersey
New Orleans
New York
New York City
Newron
NiCox
Niacin
Nick R. Bryan
Nigeria
Nivestim
NormOxys
North Carolina
Northwestern
Northwestern University
NovImmune
NovaBay Pharmaceuticals
Novagali
Novartis
Novelos
Novo Nordisk
Noxxon pharma
Nupathe
Nutrition / Diet
Nycomed
OSI Pharmaceuticals
Obesity / Weight Loss / Fitness
Ofirmev
Olanzapine
Olga Anagnostou
Olympus IS-10 Film Camera
Omid Farokhzad
OncoMed Pharmaceuticals
Oncology
Online Marketing
Ontario
Onyx Pharmaceuticals
OptiNose
Oracle
Oralair
Orexigen Therapeutics
Orexo
Osteonecrosis
Otonomy
PI3-K
PITTSBURGH
PLX-PAD
PLX4032
PPAR-g
PPD
PRA International
PRX302
Pacific Biosciences
Pain / Anesthetics
Paris
Patients
Patricia Kilian
Pearson Chair
PecFent
Pediatrics / Children's Health
Penelope
Pennsylvania
Penwest Pharmaceuticals
Perifosine
Pervasis Therapeutics
Pfizer
Pharma Strategy
Pharmaceutical Sales and Marketing
Pharmasset
Pharmathene
Pharming
Phase Forward
Phase I
Phenomix Corporation
Philadelphia
Pixantrone
Plexxikon
Pluristem Technology
Polio
PolyTherics
Portola Pharmaceuticals
Posidur
Poxel
Pozen
Pradaxa
Precision Therapeutics
PregLem
Pregabalin
Pregnancy / Obstetrics
Primary Care / General Practice
Proceedings of the National Academy of Sciences
Program
Progressive Multifocal Leukoencephalopathy
Prolia
Propofol
Prostate / Prostate Cancer
Protalix
Protox Therapeutics
Provenge
Providence
Proximagen Neuroscience
Psychology / Psychiatry
Puerto Rico
Pulmonary Hypertension
Pyramax
Qnexa
Quaker Bioventures
Quark Pharmaceuticals
Quebec
Questions and Answers
Quetiapine
Quintiles
R&D
R&D budget
R&D spending
RNAi
Radiology / Nuclear Medicine
Ramius
Ranbaxy
Randy Seeley
Raptor Pharmaceutical
Rash
ReSearch Pharmaceutical Services
Reading
Reading Campus
Reata Pharmaceuticals
Recentin
Regeneration
Regeneron Pharmaceuticals
Regulation
Regulus Therapeutics
Renal Failure
Repros
Research
RespiVert
Respiratory / Asthma
Response Genetics
Restless Legs Syndrome
Retacrit
Revimmune
Rezulin
Rhabdomyolysis
Rheumatoid Arthritis
Rhode Island
Rhode Island Hospital
Rhucin
Ricardo Azziz
Richard L. Sidman
Rifampicin
Robert Farese
Robert Gros
Robert Langer
Robert V. Farese
Robert Wood Johnson
Roche
Rochester
Rochester Medical Center
Roger D. Soloway
Roman Hovorka
Roux-en-Y
Rubino
SEATTLE
SFE Strategy
STX-100
SV Life Sciences Advisers
Sales
San Diego
San Francisco
Sandoz
Sanford-Burnham
Sangamo BioSciences
Sanjiv Shah
Sanofi-Aventis
Santarus
Santhera
Sarah A. Gaussoin
Sarah A. Jaramillo
Sarah Tishkoff
Saskatchewan
Sativex
Schering-Plough
Scotland
Scott Williams
Seattle Genetics
Selecta Biosciences
Seniors / Aging
Sepracor
Severin Schwan
Shannon L. Rhodes
Shin Poong Pharmaceutical
Shionogi
Shire Pharmaceuticals
Sigma Pharmaceuticals
Silvia Guatimosim
Simvastatin
Sinai
Sinai Medical Center
Singapore
Sirtris Pharmaceuticals
SkyePharma
Sleep / Sleep Disorders / Insomnia
Social Issues
Social Media
Sombat Treeprasertsuk
Sonus Pharmaceuticals
Soren Friis
South America
Spain
SparVax
Sports Medicine / Fitness
Stallergenes
Stedesa
Stem Cell Research
Stem Cell Therapeutics
Stempeutics
Stephen L. Archer
Stephen L. Hauser
Stephen Woods
Steve Kaldor
Steve Reed
Steven Burrill
Steven Quay
Stimuvax
Stroke
Stromedix
Stuart Rich
Suneil Koliwad
Supply Chain
Surfaxin
Susan Molineaux
Susanne Mohr
Sweden
Swine Flu
Sylvia Wassertheil-Smoller
Synthetic biology
T-DM1
TL011
TRU-015
TTP399
Takeda
Talecris Biotherapeutics
Taligen Therapeutics
Tardive Dyskinesia
TargeGen
Technology
Teklamo
Tekturna
Tel-Aviv University
Tempero Pharmaceuticals
Tesaro
TetraLogic
Tetraphase Pharmaceuticals
Teva Pharmaceutical Industries
Texas
Texas A&M
Thailand
Thenappan Thenappan
Therapeutic Discovery Credit
Theratechnologies
Thessaloniki
Third Rock Ventures
This week's bedtime reading
Thrombocytopenia
Tibotec
Timothy P. Hofer
Tinzaparin
Topical Anesthetics
Topiramate
Toronto
TransTech
Transdermal patches
Transition Therapeutics
Transplantation
Transplants / Organ Donations
Trastuzumab-DM1
Trevena
Trinity College Dublin
Trius Therapeutics
Trophos
Trubion Pharmaceuticals
U.S. Centers for Disease Control and Prevention
U.S. Department of Health and Human Services
U.S. Food and Drug Administration
U.S. News World Report
UCB
UCLA
UCLA Medical Center
USD
United Kingdom
United States
University College London
University Hospital
University Medical Center
University deal
University of California, San Francisco
University of Cincinnati
University of Florida
University of Iowa
University of North Carolina
University of Pennsylvania
University of Pennsylvania, Philadelphia
University of Pittsburgh
University of Pittsburgh Graduate School
University of Rochester
University of Texas Medical Branch
University of Toronto
University of Western Ontario
Urology / Nephrology
VR315
VX-770
Vaccine
Valeant Pharmaceuticals
Vanderbilt University
Vania Prado
Varenicline
Vascular
Vatican
Vaximm
Vectura Group
Venrock Associates
Venture Capital fund
Vernalis
Vicept
Victory Pharma
Viiv
Virtual model
Vitamin E
Vivus
WINSTON-SALEM
Wake Forest University
Warfarin
Water – Air Quality / Agriculture
Watson Pharmaceuticals
Weather
Weight loss pills
Wellcome Trust Clinical Research Facility
West Coast
Wilex
William T Lowrance
Wisconsin
WuXi
Wylie Vale
XL184
XMT-1107
Xarelto
Xenoport
Xiamen Innovax Biotech
Yaacov Drory
Yariv Gerber
Yedidya (Didi) Dotan
Yeshiva University
Yeshiva University Albert Einstein College of Medicine
Zalbin
Zogenix
Zonisamide
adjuvant
adult stem cells
alogliptin
amputation
amyloid beta
animal rights activists
animal testing
antibiotic
apixaban
apoptosis
arrhythmia
arthritis
atherosclerosis
australia
autism
avanafil
back pain
bacterial infection
bankruptcy
bapineuzumab
bariatric surgery
biodefense
biomarkers
biosimilar
biotech insider trading
biotech investing
biotech jobs
biotech patent news
biotech tax credit
birth control
blindness
blood glucose
boceprevir
body mass index
brain cancer
cabazitaxel
calcitonin
cambridge massachusetts
canada
cancer care
cancer therapeutics
cancer vaccine
cancers
cardiac disease
cardiac hypertrophy
cardiovascular disease
ceftobiprole
chemical
china
cholangitis
cholestasis
cholesterol
chronic
chronic HCV infection
cirrhosis
cladribine
collaborations
colorectal cancer
coma
connective tissue disease
contraceptive
coronary disease
coronary heart disease
crizotinib
cysts
danoprevir
darapladib
diabetes outside
diabetic retinopathy
diagnostics
disease
donepezil
drug delivery technology
drug development
drug discovery technologies
drug prices
drug therapies
drug therapy
dutogliptin
earnings
elagolix
elinogrel
embryonic stem cells
emerging markets
emerging outsourcing trends
endometriosis
energy
epidemic
epidemics
eprotirome
erectile dysfunction
eribulin
europe
expert advice
fatty liver
febit
female sexual dysfunction
flibanserin
flu vaccine
food
funding
gallstone
gallstones
gastric by-pass surgery
gastrointestinal surgery
gene therapy
genomics
genotype
glucose intolerance
gout
health
healthcare
healthcare reform
heart attack
heart attacks
heart disease
hepatitis B
hepatitis E
hepatocellular carcinoma
high blood pressure
high cholesterol
hirsutism
hormone therapy
hypoactive sexual desire disorder
hypoglycemia
iPieran
imaging
immunization
india
infectious disease
infertility
inflammation
innovative therapies
insomnia
insulin delivery
insulin injections
insulin pump
insulin resistance
insulin therapy
invasive procedures
ipilimumab
isavuconazole
job cuts
kidney cancer
kidney disease
kidney failure
l-arginine
lactose intolerance
laparoscopic surgery
layoffs
legislation
liprotamase
liver disease
liver transplants
lixisenatide
lorcaserin
low blood pressure
low-fat diets
lung cancer
lupus
major depressive disorder
malaria
manufacturing
marizomib
medical records
metabolic disorder
metabolic disorders
milestones
mipomersen
molecular diagnostics
monoclonal antibody
motavizumab
multiple myeloma
muscle weakness
muscular dystrophy
myocardial infarction
myocardial infarctions
nanotechnology
naproxcinod
necrosis
neurocrine biosciences
neurodegenerative disorder
neurosurgery
obatoclax
ocrelizumab
ofatumumab
orphan drug status
outsourcing
ovarian cancer
ovarian cysts
p53 biomarker
pain
pain therapy
pancreatic cancer
pancreatitis
partnership
patent expiration
peroxisome proliferator-activated receptor
pharmacogenomic
phenoxodiol
pipeline
pirfenidone
plinabulin
polycystic ovary syndrome
preclinical
procedures
proellex
prostate cancer
radiation
radiation treatment
rare diseases
regenerative medicine
regorafenib
renal cancer
renal cell carcinoma
restructuring
resuscitation
resveratrol
ridaforolimus
rivaroxaban
sales and marketing
salsalate
savella
science
seizures
sequencing
series c
shortness of breath
sickness
skin cancer
small molecules
spin-off
spinal cord injuries
statins
stem cells
sub-Saharan Africa
surgery
tanezumab
taspoglutide
telaprevir
telemedicine
tesamorelin
the 2009 Outstanding Scientific Achievement Award
the American College
the American Journal
the European Heart Journal
the European Respiratory Journal
the Proceedings of the National Academy of Sciences
the University of Chicago
the University of Iowa
the University of Michigan
the University of Pennsylvania
toremifene
total body irradiation
translational research
transparency
treatment of cancer
trends
tumor
twitter
type 2 diabetes
ulipristal
ultrasound
undefined
vaccines
vascular disease
vernakalant
vertex
vipadenant
vitamin D
vitamin D deficiency
vitamin deficiency
west Africa
workforce expansion
zalutumumab
zibotentan
Rochester
Researchers make advances in understanding causes, treatments and outcomes of liver disease
NEW ORLEANS, LA (May 2, 2010) -- Non-alcoholic fatty liver disease (NAFLD), which may soon be the leading indication for liver transplant, is found to be significantly associated with worse transplant outcomes.read...
READ THE FULL ARTICLE >>
Event & News Updates
Sign up to receive breaking news as well as receive other site updates!
Enter your email address:
Amazon.com Widgets
Our Sponsors
Recent Posts
Cord Blood America Reports that Umbilical Cord Blood Stem Cells Are Now Being Used in Experimental Effort to Treat Type 1 Diabetes
Increase In Physician Referrals Could Lead To Increase In Health Care Costs
High-Cost Screening Instead Of More Effective Tests Usually Offered To Neuropathy Patients
Saliva Test Could Replace Blood Test For Diabetics
Nurturing Mothers Rear Physically Healthier Adults
Sources
A Word from Kathryn
Diabetes News From Medical News Today
DiabetesMine: the all things diabetes blog
Eat Renal-Friendly, with June Martin
Endocrine Metabolic Medical Center Blog
eyeforpharma.com | Pharma strategy for the busy executive -
FierceBiotech
Gibbs Biomedical Consulting
Pharmacovigilance
PhysioGenix blogs
PR Newswire: Biotechnology
PR Newswire: Clinical Trials & Medical Discoveries
PR Newswire: Health
Renal BizBlog – Keith Chartier
Renal Business News Only Feed
Renal Business Today Articles
renal tsar’s blog
ScienceBlog.com – diabetes
ScienceBlog.com – hypertension
Plugin by wpburn.com
wordpress themes